We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The World Health Organization (WHO) have issued a medical alert about a batch of substandard (contaminated) medication identified in two countries, Marshall Islands and Federated States of Micronesia. Substandard medical products are products that fail to meet either their quality standards or specifications.
The affected medication is GUAIFENESIN SYRUP TG SYRUP, an expectorant used to relieve chest congestion and the symptoms of cough. This syrup was found to contain unacceptable amounts of diethylene glycol and ethylene glycol contaminants which can be toxic to humans when consumed and can prove fatal.
Further information about this adverse event, including the affected batch numbers of medication are detailed the WHO medical product alert
Substandard and falsified (counterfeit) medical products are a growing problem that occurs throughout the world. A wide range of substandard and counterfeit medicines are available, including pain medications, antimalarials, antibiotics, blood pressure medicine and vaccines.
If during travel a traveller requires medication for a new illness or condition they should be advised:
Travellers who take regular or intermittent medication should be encouraged to obtain these in the UK prior to travel, especially if there is any cause for concern about the legitimacy or quality of medications or medical products at their destination.
In the event that further medicines need to be obtained abroad (for example, if a trip is extended, medicines are lost or stolen or the planned itinerary is changed) then travellers, in addition to the measures above, should also be advised to:
See the TRAVAX Counterfeit Medicines and Travelling with Medicines pages for further information.